The MD/PhD (MSTP) Training Program at the University of Massachusetts Medical School (UMMS) demonstrates excellence and firm commitment of UMMS to train the next generation of physician scientists. This program is in alignment with the goals of NIH and the UMMS mission to be a leader in clinical and translational science training. The UMMS MD/PhD education integrates the curricula of the Medical School and the Graduate School of Biomedical Sciences (GSBS) with program-specific elements to train outstanding physician scientists for careers in academic medicine, biomedical and clinical population health sciences research. Our integrated program accelerates students' progress by eliminating traditional core lecture requirements, maximizing student exposure through research rotations and individual tutorials, providing flexibility and a comprehensive education in state-of-the-art research approaches and clinical disciplines. With the help of MSTP support, UMMS provides full funding for the program, including tuition waivers, annual stipends and fees, health, dental and disability insurance, which is a strong indicator of the commitment of the institutional leadership to training physician-scientists. Strengths of our program include outstanding basic science faculty, supportive institutional infrastructure, investment into translational sciences, expertise in the Quantitative Health Sciences Department, and a strong tertiary-care academic medical center that serves central Massachusetts. The 81 students currently in the program participate in the full spectrum of clinical and translational science training including thesis research in Basic Biomedical Sciences or Clinical Population Health Research. Our graduating students have remarkable publication records and preparedness for becoming independent scientist or lead in teams, rank in competitive residency and fellowship programs and advance medicine through new scientific discoveries.
The MD/PhD Training Program at the University of Massachusetts Medical School (UMMS) incorporates a dynamic training environment and an integrated curriculum in medicine and research innovations to educate and train the next generation of physician scientists. Outstanding students are selected for the program who after graduation continue careers in academic medicine, research and academic leadership positions to advance medical sciences and health care.
|Song, Chun-Qing; Wang, Dan; Jiang, Tingting et al. (2018) In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency. Hum Gene Ther 29:853-860|
|Fu, Shaliu; Wang, Qin; Moore, Jill E et al. (2018) Differential analysis of chromatin accessibility and histone modifications for predicting mouse developmental enhancers. Nucleic Acids Res 46:11184-11201|
|Aydemir, Ozkan; Janko, Mark; Hathaway, Nick J et al. (2018) Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes. J Infect Dis 218:946-955|
|Cruz, Freidrich M; Colbert, Jeff D; Merino, Elena et al. (2017) The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules. Annu Rev Immunol 35:149-176|
|Mou, Haiwei; Smith, Jordan L; Peng, Lingtao et al. (2017) CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion. Genome Biol 18:108|
|van Lutterveld, Remko; Houlihan, Sean D; Pal, Prasanta et al. (2017) Source-space EEG neurofeedback links subjective experience with brain activity during effortless awareness meditation. Neuroimage 151:117-127|
|Mercado-Matos, Jose; Matthew-Onabanjo, Asia N; Shaw, Leslie M (2017) RUNX1 and breast cancer. Oncotarget 8:36934-36935|
|Banna, Giuseppe L; Sheel, Ankur; Sheel, Varun et al. (2017) Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progression. Future Oncol 13:2429-2439|
|Werneburg, Sebastian; Feinberg, Philip A; Johnson, Kasey M et al. (2017) A microglia-cytokine axis to modulate synaptic connectivity and function. Curr Opin Neurobiol 47:138-145|
|Mou, Haiwei; Moore, Jill; Malonia, Sunil K et al. (2017) Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis. Proc Natl Acad Sci U S A 114:3648-3653|
Showing the most recent 10 out of 53 publications